Conexeu Sciences INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
Jeffrey Sharpe increased his beneficial ownership of Conexeu Sciences Inc. common stock to 5.2% following the exercise of performance warrants tied to a market capitalization milestone.
NASDAQ
Jeffrey Sharpe has increased his beneficial ownership in Conexeu Sciences Inc. to 5.4% following the vesting of performance warrants tied to market capitalization milestones.